tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
US Market
NKTR
Nektar Therapeutics
RESEARCH TOOLSreports

Nektar Therapeutics (NKTR) Income Statement

1,602 Followers

Nektar Therapeutics Income Statement

Last quarter (Q4 2025), Nektar Therapeutics's total revenue was $21.81M, a decrease of -25.25% from the same quarter last year. In Q4, Nektar Therapeutics's net income was $-36.08M. See Nektar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 55.23M$ 98.43M$ 90.12M$ 92.06M$ 101.91M
Gross Profit
$ 55.23M$ 67.74M$ 53.48M$ 70.42M$ 77.01M
Operating Expenses
$ 186.00M$ 172.94M$ 190.90M$ 310.66M$ 523.11M
Depreciation and Amortization
$ 1.03M$ 4.39M$ 7.82M$ 12.20M$ 14.15M
EBITDA
$ -129.74M$ -86.70M$ -243.11M$ -323.87M$ -461.82M
Operating Income
$ -130.77M$ -105.20M$ -137.43M$ -240.24M$ -446.10M
Other Income/Expenses
$ -33.44M$ -14.00M$ -138.83M$ -124.75M$ -77.18M
Pretax Income
$ -164.21M$ -119.20M$ -276.26M$ -364.98M$ -523.28M
Net Income
$ -164.08M$ -118.96M$ -276.06M$ -368.20M$ -523.84M
Per Share Metrics
Basic EPS
$ -9.73$ -8.68$ -21.79$ -29.51$ -42.90
Diluted EPS
$ -9.73$ -8.68$ -21.79$ -29.51$ -42.90
Weighted Average Shares Outstanding
 16.87M 13.71M 12.67M 12.48M 12.22M
Weighted Average Shares Outstanding (Diluted)
 16.87M 13.71M 12.67M 12.48M 12.22M
Currency in USD

Nektar Therapeutics Earnings and Revenue History